D. Boral Capital Reiterates “Buy” Rating for Beyond Air (NASDAQ:XAIR)

Beyond Air (NASDAQ:XAIR)‘s stock had its “buy” rating reissued by equities researchers at D. Boral Capital in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $10.00 target price on the stock.

Other equities research analysts have also issued research reports about the company. Weiss Ratings reaffirmed a “sell (e)” rating on shares of Beyond Air in a research note on Monday, December 22nd. Rodman & Renshaw initiated coverage on shares of Beyond Air in a research note on Tuesday, January 20th. They set a “buy” rating on the stock. Finally, Wall Street Zen upgraded Beyond Air to a “sell” rating in a report on Saturday. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $10.00.

Beyond Air Stock Performance

Shares of XAIR stock traded down $0.02 during mid-day trading on Tuesday, hitting $0.84. 29,507 shares of the stock were exchanged, compared to its average volume of 9,930,755. Beyond Air has a 12-month low of $0.67 and a 12-month high of $6.44. The company has a debt-to-equity ratio of 2.65, a quick ratio of 4.77 and a current ratio of 5.12. The stock has a market capitalization of $8.83 million, a price-to-earnings ratio of -0.15 and a beta of 0.41. The stock’s fifty day simple moving average is $1.14 and its two-hundred day simple moving average is $1.61.

Beyond Air (NASDAQ:XAIR) last released its quarterly earnings results on Friday, February 13th. The company reported ($0.85) EPS for the quarter, missing the consensus estimate of ($0.54) by ($0.31). Beyond Air had a negative return on equity of 268.82% and a negative net margin of 447.75%.The company had revenue of $2.19 million for the quarter, compared to analysts’ expectations of $2.15 million. On average, analysts forecast that Beyond Air will post -0.79 EPS for the current year.

Institutional Investors Weigh In On Beyond Air

A number of institutional investors have recently made changes to their positions in XAIR. Geode Capital Management LLC lifted its position in shares of Beyond Air by 1.5% in the 2nd quarter. Geode Capital Management LLC now owns 838,319 shares of the company’s stock worth $144,000 after buying an additional 12,598 shares during the last quarter. Osaic Holdings Inc. lifted its holdings in Beyond Air by 26.4% in the second quarter. Osaic Holdings Inc. now owns 162,560 shares of the company’s stock worth $29,000 after acquiring an additional 34,000 shares during the last quarter. Virtu Financial LLC acquired a new position in Beyond Air in the third quarter valued at approximately $48,000. Alyeska Investment Group L.P. bought a new position in shares of Beyond Air during the third quarter valued at approximately $1,753,000. Finally, Alpine Global Management LLC acquired a new stake in shares of Beyond Air during the 3rd quarter worth approximately $25,000. 31.50% of the stock is currently owned by institutional investors.

About Beyond Air

Beyond Air, Inc is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.

The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity.